Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD ‐11
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of
AWARD
‐11
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 23, Issue 10, Pages 2242-2250
Publisher
Wiley
Online
2021-07-01
DOI
10.1111/dom.14465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
- (2021) Juan P. Frias et al. DIABETES CARE
- PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes
- (2019) Vanita R. Aroda et al. DIABETES CARE
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
- (2019) Eric Nolen-Doerr et al. Current Obesity Reports
- GLP‐1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis including the REWIND and PIONEER 6 trials
- (2019) Dario Giugliano et al. DIABETES OBESITY & METABOLISM
- Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials
- (2019) Vanita R. Aroda et al. DIABETES OBESITY & METABOLISM
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes
- (2018) Louis S. Matza et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Science of Obesity Management: An Endocrine Society Scientific Statement
- (2018) George A Bray et al. ENDOCRINE REVIEWS
- Long-Term Weight Loss and Metabolic Health in Adults Concerned With Maintaining or Losing Weight: Findings From NHANES
- (2018) Gregory Knell et al. MAYO CLINIC PROCEEDINGS
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Type 2 diabetes
- (2017) Sudesna Chatterjee et al. LANCET
- Relationship between weight change and glycaemic control in patients with type 2 diabetes receiving once-weekly dulaglutide treatment
- (2016) G. E. Umpierrez et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program
- (2016) Johan Jendle et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Reliability, Validity, and Responsiveness of the Impact of Weight on Self-Perceptions Questionnaire (IW-SP) in Individuals with Type 2 Diabetes and Obesity
- (2015) Risa P. Hayes et al. Diabetes Technology & Therapeutics
- Effects of GLP-1 on appetite and weight
- (2014) Meera Shah et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes
- (2014) André J Scheen et al. Lancet Diabetes & Endocrinology
- GLP-1 receptor agonists: a review of head-to-head clinical studies
- (2014) Jennifer M. Trujillo et al. Therapeutic Advances in Endocrinology and Metabolism
- Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
- (2013) E. R. Seaquist et al. DIABETES CARE
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Test–Retest, Responsiveness, and Minimal Important Change of the Ability to Perform Physical Activities of Daily Living Questionnaire in Individuals with Type 2 Diabetes and Obesity
- (2012) Risa P. Hayes et al. Diabetes Technology & Therapeutics
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Ability to Perform Daily Physical Activities in Individuals with Type 2 Diabetes and Moderate Obesity: A Preliminary Validation of the Impact of Weight on Activities of Daily Living Questionnaire
- (2011) Risa P. Hayes et al. Diabetes Technology & Therapeutics
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
- (2009) Daphne P Guh et al. BMC PUBLIC HEALTH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now